Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer

BACKGROUND: Expression of transglutaminase 2 (TGase 2) is related to invasion and resistance to chemotherapeutic agents in several cancer cells. However, there has been only limited clinical validation of TGase 2 as an independent prognostic marker in cancer. METHODS: The significance of TGase 2 exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Chang-Min, Jang, Se-Jin, Park, Seong-Yeol, Choi, Yong-Bock, Jeong, Jae-Heon, Kim, Dae-Seok, Kim, Hyun-Kyoung, Park, Kang-Seo, Nam, Byung-Ho, Kim, Hyeong-Ryul, Kim, Soo-Youl, Hong, Kyeong-Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196741/
https://www.ncbi.nlm.nih.gov/pubmed/21943122
http://dx.doi.org/10.1186/1476-4598-10-119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196741/
https://www.ncbi.nlm.nih.gov/pubmed/21943122
http://dx.doi.org/10.1186/1476-4598-10-119

Ejemplares similares